Qingbin Xu

633 total citations
26 papers, 500 citations indexed

About

Qingbin Xu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Qingbin Xu has authored 26 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Qingbin Xu's work include Pulmonary Hypertension Research and Treatments (5 papers), Cardiac Ischemia and Reperfusion (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Qingbin Xu is often cited by papers focused on Pulmonary Hypertension Research and Treatments (5 papers), Cardiac Ischemia and Reperfusion (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Qingbin Xu collaborates with scholars based in China and United States. Qingbin Xu's co-authors include Ru Zhou, Guidong Dai, Ping Zheng, Lin Yan, Jie Zheng, Ping Ma, Weijun Kong, Jinxin Liu, Yang Wang and Yang Yang and has published in prestigious journals such as Small, European Journal of Pharmacology and Medicine.

In The Last Decade

Qingbin Xu

24 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingbin Xu China 12 179 103 91 76 62 26 500
Shangfei He China 11 130 0.7× 95 0.9× 48 0.5× 34 0.4× 25 0.4× 20 410
Srinivasan Vedantham India 13 293 1.6× 104 1.0× 131 1.4× 40 0.5× 14 0.2× 29 769
Annie Turkieh France 11 307 1.7× 146 1.4× 55 0.6× 35 0.5× 24 0.4× 22 713
Chongyang Ma China 18 264 1.5× 40 0.4× 25 0.3× 80 1.1× 26 0.4× 51 824
Marawan A. Elbaset Egypt 18 220 1.2× 59 0.6× 56 0.6× 30 0.4× 47 0.8× 70 803
Emilie Dubois‐Deruy France 14 410 2.3× 245 2.4× 90 1.0× 33 0.4× 54 0.9× 25 922
Minghua Xian China 15 245 1.4× 30 0.3× 29 0.3× 112 1.5× 43 0.7× 53 634
Lianpin Wu China 16 567 3.2× 179 1.7× 63 0.7× 26 0.3× 46 0.7× 41 886
Judith Bernal‐Ramírez Mexico 14 184 1.0× 99 1.0× 43 0.5× 18 0.2× 48 0.8× 24 466

Countries citing papers authored by Qingbin Xu

Since Specialization
Citations

This map shows the geographic impact of Qingbin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingbin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingbin Xu more than expected).

Fields of papers citing papers by Qingbin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingbin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingbin Xu. The network helps show where Qingbin Xu may publish in the future.

Co-authorship network of co-authors of Qingbin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingbin Xu. A scholar is included among the top collaborators of Qingbin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingbin Xu. Qingbin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yang, et al.. (2024). Exploring the Mechanism of Influence of Wolfberry (Lycium barbarum L.) on Pulmonary Arterial Hypertension Based on Network Pharmacology and Molecular Docking. Letters in Drug Design & Discovery. 21(17). 4005–4025. 1 indexed citations
2.
Li, Lingling, et al.. (2024). Construction of a N-CDs/AuNCs@ZIF-8-assisted ratiometric fluorescent nanosensor for glyphosate detection in edible and medicinal malt. Food Chemistry X. 24. 101983–101983. 6 indexed citations
3.
Xu, Qingbin, Pengyue Song, Ying Li, et al.. (2023). 3D nanocake-like Au-MXene/Au pallet structure–based label-free electrochemical aptasensor for paraquat determination. Microchimica Acta. 191(1). 33–33. 13 indexed citations
4.
Xia, Tian, et al.. (2023). Preparation of betaine injection and its therapeutic effect in pulmonary arterial hypertension. Basic & Clinical Pharmacology & Toxicology. 134(2). 219–230. 2 indexed citations
5.
Xu, Qingbin, et al.. (2023). Development of UiO‐66‐NH 2 and RuO 2 composite‐modified carbon fiber for highly sensitive sensing of ferulic acid. Rare Metals. 42(11). 3630–3637. 4 indexed citations
6.
Xu, Qingbin, et al.. (2023). An electrochemical sensor founded on heterogeneous MXene & MOF composite for tanshinol sensing. Talanta. 268(Pt 1). 125344–125344. 45 indexed citations
7.
Li, Ben, Ting Ge, Xi Li, et al.. (2023). A Single-Center Study Using IVUS to Guide Rotational Atherectomy for Chronic Renal Disease’s Calcified Coronary Artery. Journal of Multidisciplinary Healthcare. Volume 16. 1085–1093. 3 indexed citations
8.
Liu, Siyun, et al.. (2023). Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension. Personalized Medicine. 20(2). 183–192. 5 indexed citations
9.
Wang, Jialing, Qingbin Xu, Jun Fan, et al.. (2021). Betaine alleviates right ventricular failure via regulation of Rho A/ROCK signaling pathway in rats with pulmonary arterial hypertension. European Journal of Pharmacology. 910. 174311–174311. 9 indexed citations
10.
Zhang, Min, Zhi Chang, Peng Zhang, et al.. (2019). Protective effects of 18β-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A/Rho kinsase pathway. Chemico-Biological Interactions. 311. 108749–108749. 21 indexed citations
11.
Zhang, Min, Zhi Chang, Peng Zhang, et al.. (2019). Protective Effects of 18β-Glycyrrhetinic Acid on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats. Frontiers in Pharmacology. 10. 13–13. 24 indexed citations
12.
Xu, Qingbin, et al.. (2017). Motion Analysis for the Working Device of Loader Based on SolidWorks Motion. IJEIR. 6(2). 65–68. 1 indexed citations
13.
Zhou, Ru, et al.. (2016). Oxymatrine attenuated isoproterenol-induced heart failure in rats via regulation of COX-2/PGI2 pathway. Biomedicine & Pharmacotherapy. 84. 1359–1366. 22 indexed citations
14.
Zhang, Wei, Jian Zhang, Yan-Sheng Kang, et al.. (2014). Cardioprotective effects of oxymatrine on isoproterenol-induced heart failure via regulation of DDAH/ADMA metabolism pathway in rats. European Journal of Pharmacology. 745. 29–35. 40 indexed citations
15.
Li, Xiaobing, Xiao Wang, Ning Deng, et al.. (2012). Regulation of endothelial nitric oxide synthase and asymmetric dimethylarginine by matrine attenuates isoproterenol-induced acute myocardial injury in rats. Journal of Pharmacy and Pharmacology. 64(8). 1107–1118. 28 indexed citations
16.
Xu, Qingbin. (2011). A study of gene ploymorphism of N5,10-methylenetetrahydrofolate reductase (MTHFR) between Hui and Han nationalities in Ningxia and the relationship with essential hypertension. Chongqing Yike Daxue xuebao. 1 indexed citations
17.
Xu, Qingbin. (2011). The Association between Gene Polymorphisms of N~(5,10)-Methylenetetrahydrofolate Reductase and Essential Hypertension in Patients of Ningxia Hui Nationality. 2 indexed citations
18.
Ma, Ping, Xin Wang, Wei Zhang, et al.. (2011). Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism. European Journal of Pharmacology. 666(1-3). 165–172. 33 indexed citations
19.
Zhou, Ru, Qingbin Xu, Ping Zheng, et al.. (2008). Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. European Journal of Pharmacology. 586(1-3). 244–250. 150 indexed citations
20.
Zhang, Fu‐Min, Zhijian Yang, Yijiang Chen, et al.. (2003). Clinical Cellular Cardiomyoplasty:. Journal of Cardiac Surgery. 18(3). 268–273. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026